Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
EFFECTIVE IMMEDIATELY (3/25/2020): Oregon Board of Pharmacy adopts temporary emergency rule (OAR 855-007-0085) prohibiting the dispensing of chloroquine and hydroxychloroquine for presumptive treatment or prevention of COVID-19 infection to preserve supplies for treatment of malaria, inflammatory conditions, and documented COVID-19 infection in hospitalized or residential patients. (see Prescription Therapy for COVID-19 Patients Informational/FAQs)
In order to help contain the spread of the coronavirus (COVID-19), the Oregon Board of Pharmacy has closed its offices to the general public and Board staff will be following the social distancing measures outlined in Governor Brown’s Executive Order No. 20-12. Please be advised that it may take longer than usual to receive a response.